Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Eifel PJ, Winter K, Morris M et al. (2004) Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 22:872–880
Esthappan J, Mutic S, Malyapa RS et al. (2004) Treatment planning guidelines regarding the use of CT/PET-guided IMRT for cervical carcinoma with positive paraaortic lymph nodes. Int J Radiat Oncol Biol Phys 58:1289–1297
Mutic S, Malyapa RS, Grigsby PW et al. (2003) PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes-a dose-escalation treatment planning study. Int J Radiat Oncol Biol Phys 55:28–35
Low DA, Grigsby PW, Dempsey JF et al. (2002) Applicator-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 52:1400–1406
Schefter TE, Kavanagh BD, Wu Q et al. (2002) Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally-advanced cervix cancer. Med Dosim 27:177–184
Corn BW, Lanciano RM, Greven KM et al. (1994) Impact of improved irradiation technique, age and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis. J Clin Oncol 12:510–515
Landoni F, Maneo A, Colombo A et al. (1997) Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350:535–540
Sedlis A, Bundy BN, Rotman MZ et al. (1999) A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study. Gynecol Oncol 73:177–183
Eifel PJ, Levenback C, Wharton JT et al. (1995) Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 32:1289–1300
Mundt AJ, Mell LK, Roeske JC (2003) Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 56:1354–1360
Jackson A, Skwarchuk MW, Zelefsky MJ et al. (2001) Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 49:685–698
Koper PC, Heemsbergen WD, Hoogeman MS et al. (2004) Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 58:1072–1082
Huang EH, Pollack A, Levy L et al. (2002) Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 54:1314–1321
Ahamed A, D’Souza W, Salehpour M, Iyer R, Tucker SL, Jhingran A, Eifel PJ (2005) Intensity-modulated radiation therapy after hysterectomy: Comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size. Int J Radiat Oncol Biol Phys 62(4):1117–1124
Eifel PJ, Jhingran A, Bodurka DC et al. (2002) Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol 20:3651–3657
Mundt AJ, Lujan AE, Rotmensch J et al. (2002) Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 52:1330–1337
Mundt AJ, Roeske JC, Lujan AE et al. (2001) Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies. Gynecol Oncol 82:456–463
Brixey CJ, Roeske JC, Lujan AE et al. (2002) Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 54:1388–1396
Lujan AE, Mundt AJ, Yamada SD et al. (2003) Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys 57:516–521
Grigsby PW, Singh AK, Siegel BA et al. (2004) Lymph node control in cervical cancer. Int J Radiat Oncol Biol Phys 59: 706–712
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Eifel, P.J. (2006). Intensity-modulated Radiation Therapy for Carcinomas of the Uterine Cervix and Endometrium. In: Bortfeld, T., Schmidt-Ullrich, R., De Neve, W., Wazer, D.E. (eds) Image-Guided IMRT. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-30356-1_32
Download citation
DOI: https://doi.org/10.1007/3-540-30356-1_32
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-20511-1
Online ISBN: 978-3-540-30356-5
eBook Packages: MedicineMedicine (R0)